Andelyn Biosciences

IN THE PRESS

Press Releases

Andelyn and Its Curator® Platform Achieve First FDA-Approved Commercial Gene Therapy Manufacturing Milestone Following FDA Approval of Ultragenyx’s FAYUVI™ to Treat Sanfilippo Syndrome Type A (MPS IIIA)

September 20, 2026

·

3 min read

Press Releases

Andelyn Biosciences to Scale Manufacturing for Genprex’s Diabetes Gene Therapy Program

September 1, 2026

·

5 min read

Press Releases

Andelyn Biosciences to Implement Curator® Platform to Develop and Manufacture Gene Therapy AAV9-GM2 for Queen’s University to Treat GM2 Gangliosidoses

August 18, 2026

·

4 min read

Press Releases

Andelyn Biosciences Receives Dark Horse Consulting Certification of Gene Therapy Manufacturing Systems and Capabilities within its Initiative for Certification of Manufacturing Capabilities (ICMC™) Program

May 13, 2026

·

5 min read

Press Releases

Andelyn Biosciences Launches LVV Curator® Platform, Bringing Proven Viral Vector Platform Pedigree to Lentiviral Vector Manufacturing for Cell Therapies

May 12, 2026

·

4 min read

Press Releases

Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing

April 21, 2026

·

4 min read

Press Releases

Andelyn Biosciences Partners with Evolyra Therapeutics for the Clinical Manufacturing of Gene Therapies for the Treatment of Limb-Girdle Muscular Dystrophies

April 14, 2026

·

4 min read

Press Releases

Andelyn Biosciences Establishes The Andelyn Foundation to Support Families Living with Rare and Ultra-Rare Diseases

March 10, 2026

·

4 min read

Press Releases

Andelyn Biosciences to Apply the AAV Curator® Platform to Manufacture Clinical Grade AAV for Drake Rayden Foundation for the Treatment of Nonketotic Hyperglycinemia

February 17, 2026

·

4 min read

Press Releases

Andelyn Biosciences Announces Partnership with Jaguar Gene Therapy to Provide Late-Stage PPQ Manufacturing

December 8, 2025

·

5 min read

AWARDS

JOBS